"Marshfield Clinic Cancer Center - Eau Claire is a specialized medical group dedicated to the diagnosis and treatment of various cancer and many blood disorders. On-site staff includes board-certified hematologists and oncologists, oncology-certified nurses (OCN), pharmacists, oncology social worker, a financial assistance coordinator, patient navigator and medical assistants."

During the past decade, Marshfield Clinic Cancer Center at Sacred Heart conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 86 clinical trials were completed, i.e. on average, 260.6% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 40 clinical trials were completed. i.e. 4000% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marshfield Clinic Cancer Center at Sacred Heart" #1 sponsor was "National Cancer Institute (NCI)" with 76 trials, followed by "SWOG Cancer Research Network" with 23 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "Gynecologic Oncology Group" with 9 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marshfield Clinic Cancer Center at Sacred Heart" #1 collaborator was "National Cancer Institute (NCI)" with 57 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Marshfield Clinic Cancer Center at Sacred Heart" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Fallopian Tube Transitional Cell Carcinoma" (8 trials), "Recurrent Ovarian Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials) and "Ovarian Transitional Cell Carcinoma" (7 trials). Many other conditions were trialed in "Marshfield Clinic Cancer Center at Sacred Heart" in a lesser frequency.

Most popular intervention types in "Marshfield Clinic Cancer Center at Sacred Heart" are "Drug" (111 trials), "Other" (102 trials), "Biological" (55 trials), "Procedure" (21 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (72 trials), "Quality-of-Life Assessment" (38 trials), "Paclitaxel" (22 trials), "Bevacizumab" (19 trials) and "Carboplatin" (18 trials). Other intervention names were less common.

The vast majority of trials in "Marshfield Clinic Cancer Center at Sacred Heart" are 102 trials for "All" genders, 29 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Marshfield Clinic Cancer Center at Sacred Heart". undefined are not yet recruiting, 10 are recruiting, 66 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 45 completed trials in Marshfield Clinic Cancer Center at Sacred Heart, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Marshfield Clinic Cancer Center at Sacred Heart, 3 "Phase 1" clinical trials were conducted, 53 "Phase 2" clinical trials and 79 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".